Simultaneous and Rapid Determination of Six Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Using HPLC-MS/MS.
Yanping LiuHua LiuZhewei XiaZhi-Peng WangYunlei YunGuanying ZhangLifeng HuangShou-Hong GaoWan-Sheng ChenPublished in: International journal of analytical chemistry (2021)
This newly developed method was sensitive, simple, and robust and could be used in therapeutic drug monitoring of six tyrosine kinase inhibitors in NSCLC patients.
Keyphrases
- ms ms
- end stage renal disease
- small cell lung cancer
- ejection fraction
- newly diagnosed
- chronic kidney disease
- solid phase extraction
- peritoneal dialysis
- prognostic factors
- liquid chromatography tandem mass spectrometry
- chronic myeloid leukemia
- advanced non small cell lung cancer
- simultaneous determination
- ultra high performance liquid chromatography